Rachel Landis

Rachel Landis

Rachel Landis (she/her) is from New York City and grew up at Congregation Rodeph Sholom on the Upper West Side. She graduated cum laude from Brandeis University where she studied Politics, Economics, and Art History. While at Brandeis, Rachel wrote her thesis on the changing relationship between women elected to state office and reproductive health care legislation. She also was involved in activism and the arts on campus. Rachel also spent much of her college career serving as the National Policy Director for Generation Ratify, the youth organization working towards the ratification of the Equal Rights Amendment.

Rachel was very involved with the Reform movement growing up, spending nine summers at URJ Camp Harlam (including one as a staff member) and serving on the regional board of NFTY-NAR during her senior year of high school. While attending the RAC L'Taken seminar several times throughout high school, Rachel became passionate about the connections between Judaism and social justice and has always strived to connect the two wherever she can. Rachel's legislative portfolio includes reproductive health and rights, gender equity, and partnership with the Women of Reform Judaism. She will serve as the inaugural Linda Rae Sher Legislative Assistant, supported by the generous gifts of friends of Linda Sher and Women of Reform Judaism.

My Reflection as WRJ's Legislative Assistant

Rachel Landis

I first learned about Women of Reform Judaism (WRJ) at NFTY convention in 2019. In a crowded convention hall, many of the URJ’s affiliate organizations and programs were there to advertise themselves to the hundreds of students who had gathered in Dallas

The U.S. Supreme Court 2024: A Recap

Rachel Landis

Last week, the U.S. Supreme Court wrapped up its 2023-2024 term and issued the last of their decisions. In decisions related to guns, abortion access, homelessness, and more, the Court continues to be one of the most relevant policymakers in the United States

The Future of Medication Abortion in the United States

Rachel Landis

On December 13, 2023, the Supreme Court decided to hear a case that will determine the future of access to reproductive healthcare in the United States: U.S. Food and Drug Administration et al, v. Alliance for Hippocratic Medicine et al.

Mifepristone (often